Charles Flexner
MD
Johns Hopkins University School of Medicine, United States
2nd International Workshop On Long Acting Anti-Infectives (LAAI) 2026
What's New
- The 2nd International Workshop On Long Acting Anti-Infectives (LAAI) 2026 will be held on 21-22 May 2026 in Philadelphia, PA, United States!
About this Program
The 2nd International Workshop on Long-Acting Anti-Infectives (LAAI) is a dynamic forum advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies.
This year’s program will examine the evolving landscape of HIV prevention and treatment, while broadening discussions to tuberculosis, malaria, hepatitis, and non-TB mycobacterial diseases. Sessions will explore innovative delivery platforms, behavioral and adherence strategies, drug resistance, and implementation challenges across diverse populations.
Through interactive talks, panel discussions, and debates, participants will engage with the latest scientific and programmatic insights shaping the next generation of long-acting therapies. By fostering collaboration among academia, industry, and global health partners, LAAI aims to drive innovation that improves access, adherence, and long-term outcomes across infectious diseases.
Organizing Committee
Daniel Kuritzkes
MD
Brigham and Women's Hospital / Harvard Medical School, United States
Kimberly Scarsi
PharmD, MS, FCCP
University of Nebraska Medical Center (UNMC), United States
Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
